| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |